Skip to main content

2022 Enacted Medicare Cuts Analysis

DataGen’s 2022 Enacted Medicare Cuts Analysis shows how hospitals have been impacted by existing Medicare fee-for-service provider payment cuts enacted by Congress to achieve Medicare payment policy and/or long-term deficit reduction goals. This analysis is provided to DataGen clients for advocacy purposes only.

The impacts shown in this analysis include the major legislative, regulatory and quality cuts enacted since 2010 and are described below. 

Enacted legislative cuts analyzed:

  • Medicare marketbasket, Medicare Disproportionate Share Hospital and quality adjustments authorized by the Affordable Care Act of 2010; note that for this analysis, quality adjustments are broken out into their own category; 
  • the effect of the 2.0% across-the-board sequestration reduction to payments authorized by the Budget Control Act of 2011, and the 4.0% sequestration reduction resulting from the calendar year 2021 triggering of the Statutory Pay-As-You-Go Act of 2010 (PAYGO); 
  • inpatient coding adjustment reductions authorized by the American Taxpayer Relief Act  of 2012; 
  • the reduction in bad debt payments authorized by the Middle Class Tax Relief and Job Creation Act of 2012;
  • payment adjustments for services paid for under the clinical laboratory fee schedule authorized by the Protecting Access to Medicare Act of 2014;
  • reduction of Outpatient Prospective Payment System payments to non-excepted, off-campus sites to a level equivalent to that paid under the Medicare Physician Fee Schedule, required by the Bipartisan Budget Act of 2015;
  • marketbasket adjustments authorized by the Medicare Access and CHIP Reauthorization Act of 2015;
  • change in Home Health PPS payments resulting from the implementation of the Patient-Driven Grouping Model; and
  • payment reductions authorized by the Bipartisan Budget Act of 2018, including adding hospice to the Inpatient PPS short-stay, post-acute care transfer policy.

Enacted regulatory cuts analyzed:

  • regulatory coding adjustments implemented by CMS;
  • 2.0% reduction to the CY 2016 outpatient marketbasket update for rate inflation due to packaging of laboratory payments;
  • long-term care hospital site-neutral payment adjustment implemented in the federal fiscal year 2016 final rule;
  • payment impacts resulting from CMS’ reduction in OPPS payments for 340B Program-purchased drugs;
  • reduction in payments for Wholesale Acquisition Cost-based drugs from WAC+6% to WAC+3%;
  • change in SNF PPS payment methodology from the RUG-IV system to the Patient-Driven Payment Model; and
  • reduction of OPPS payments for clinic services provided at excepted off-campus sites to a level equivalent to that paid under the Medicare Physician Fee Schedule.

The quality-based payment reform impacts analyzed reflect the IPPS payment adjustments related to three mandatory quality-based payment reform initiatives: the Value-Based Purchasing, Readmissions Reduction and Hospital-Acquired Conditions Reduction programs.

These cuts could have a major impact on hospital finances and operations in the coming years. To learn more about this impact and about how to thrive in alternative payment models, contact us today.

Comments

Popular posts from this blog

Patient safety culture survey: Why collect data?

The Agency for Healthcare Research and Quality defines patient safety culture as "the extent to which an organization's culture supports and promotes patient safety." Patient safety culture is influenced by the values, beliefs and norms of healthcare practitioners and other staff. Since these concepts tend to be abstract, organizations looking to improve their patient safety culture must focus on identifying and measuring patient safety-related behaviors.  In this introductory blog, we'll touch on the importance of patient safety data and how it can help create a baseline. From there, you can gain a clearer idea of how to benchmark your facility to create effective patient safety culture improvement strategies.  Why collect patient safety data?  The best way to examine patient safety culture at the department, organization and system levels is to measure data. An organization can implement many different patient safety culture strategies. However, for them to be most

CMS Enhancing Oncology Model Updates: RFA Issued for Second Cohort

Key CMMI updates to the EOM  The Center for Medicare and Medicaid Innovation (CMMI) released exciting updates to the Enhancing Oncology Model (EOM) along with a new opportunity for a second cohort of participants.   The EOM aims to enhance the quality of care for cancer patients while reducing costs under the Medicare fee-for-service program. The updates come on the heels of lower-than-expected model participation .   This blog will discuss key EOM updates, application details, eligibility requirements and important deadlines.  New cohort opportunity  Request for applications: CMS issued an RFA to recruit a second cohort of participants and payers for the EOM.  Timeline:  Second cohort start date: July 1, 2025  Second cohort end date: June 30, 2030  Initial performance period start date: July 1, 2023  Model test end date for all participants: June 30, 2030 (extended from June 30, 2028)  Notable changes to the EOM model  Model extension: The model's duration is extended by two yea